secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axsome Therapeutics, Inc. (AXSM)
CIK:        0001579428
Form:       8-K
Filed at:   2026-06-09T21:19:56+00:00
Accession:  0001193125-26-264043
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Axsome shareholders elect directors, ratify Deloitte, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Mark Saad elected Class II director with 28,675,654 votes for, 10,286,822 withheld.
- Susan Mahony elected Class II director with 29,892,131 votes for, 9,070,345 withheld.
- Ratification of Deloitte & Touche as auditor passed with 43,278,147 votes for (98.9% of votes cast).
- Non-binding advisory vote on executive compensation approved with 37,818,384 votes for (97.5% of votes cast).
- Approximately 85.1% of outstanding shares were represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526264043/0001193125-26-264043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1579428/000119312526264043/axsm-20260605.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-264043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer